Page last updated: 2024-11-10

perophoramidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

perophoramidine: from the Philippine ascidian Perophora namei; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3081926
MeSH IDM0447158

Synonyms (6)

Synonym
474779-75-4
1h,8h-pyrrolo(2',3':2,3)pyrido(4,3-o)quinindoline, 6-bromo-10,12-dichloro-2,3,14,15-tetrahydro-1-methyl-, (3ar,13bs)-rel-(+)
perophoramidine
DTXSID50963853
6-bromo-10,12-dichloro-1-methyl-2,3,14,15-tetrahydro-1h,9h-benzo[c]indolo[3,2-j]pyrrolo[3,2-e][2,6]naphthyridine
(1s)-13-bromo-4,6-dichloro-20-methyl-8,10,20,22-tetrazahexacyclo[15.7.0.01,9.02,7.011,16.017,21]tetracosa-2(7),3,5,8,11(16),12,14,21-octaene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (36.84)29.6817
2010's10 (52.63)24.3611
2020's2 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]